The No. 1 reason physicians cite for not prescribing a continuous glucose monitor is its complexity, a roadblock that DME ...

Rating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...

The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as they position themselves for future growth in the competitive diabetes ...

Feb 25 (Reuters) - Henry Schein (HSIC.O), opens new tab forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid ...

MELVILLE, N.Y.--(BUSINESS WIRE)--In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting ...

“For five years, Henry Schein has had the privilege of spotlighting promising athletic trainers through the Rising Star program,” said Eric Kearns, National Sales Director of Henry Schein ...